Position in CRNX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,981,824
+$886,198 QoQ
Shares Held
106,409
+24.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#77
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. CRNX ranks #15 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,981,824 | 106,409 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $3,095,626 | 85,232 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,619,960 | 77,765 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,974,834 | 47,415 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,453,070 | 50,524 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,257,342 | 67,303 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $3,833,983 | 74,985 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,103,967 | 60,743 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,755,704 | 61,525 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,573,098 | 54,969 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,637,569 | 46,025 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,199,354 | 40,328 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $715,574 | 39,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $570,451 | 35,520 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $667,529 | 36,477 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $575,962 | 29,326 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $591,951 | 31,740 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,071,489 | 48,815 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,561,527 | 54,964 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $998,527 | 47,436 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $933,376 | 49,516 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $910,122 | 59,563 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $838,656 | 59,437 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $657,105 | 41,934 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $785,053 | 44,809 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $647,388 | 44,040 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||